6424 results
BMC primary care,
Volume 27, Issue 1, 25 4 2025, Pages 1
Navigating chest pain online: who uses health information and what actions follow?
van Dijkman ED, de Boer YK, de Hollander EL, Numans ME, Siebelink HJ, Bonten TN
Abstract
JACC. Cardiovascular imaging,
22 4 2025, Pages S1936-878X(25)00579-0
Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry.
van Rosendael A, Nakanishi R, Bax JJ, Pontone G, Mushtaq S, Buechel RR, Gräni C, Feuchtner G, Lacaita PG, Patel AR, Singulane CC, Choi AD, Al-Mallah M, Andreini D, Karlsberg RP, Cho GW, Rochitte CE, Alasnag M, Hamdan A, Cademartiri F, Maffei E, Marques H, Gonçalves PA, Gupta H, Hadamitzky M, Khalique O, Kalra D, Mills JD, Nurmohamed NS, Knaapen P, Budoff M, Shaikh K, Martin E, German DM, Ferencik M, Oehler AC, Deaño R, Nagpal P, van Assen M, De Cecco CN, Kamperidis V, Foldyna B, Brendel JM, Cheng VY, Branch KR, Bittencourt M, Bhatti S, Polsani V, Wesbey G, Cardoso R, Blankstein R, Delago A, Pursnani A, Alsaid A, Singh V, Aquino M, Park J, Danad I
Background: The severity and extent of whole heart coronary plaque volume and stenosis can be reliably measured by artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT). Limited data are available on the potential incremental prognostic value compared with currently recommended qualitative coronary computed tomography angiography (CTA) reads and the coronary artery calcium score (CACS). Objectives: The aim of this study was to evaluate the prognostic value...
Abstract
Consciousness and cognition,
Volume 137, 17 3 2025, Pages 103964
Disentangling perceptual from non-perceptual expectation biases in short-term memory.
Koopmans JG, Thorat S, Quek GL, Peelen MV
There is debate about how many items can be represented in visual consciousness at once. Evidence against the view that visual consciousness consists of many detailed items has come from a study using the partial-report paradigm. De Gardelle et al. (2009) showed that rotated letters shown in non-cued (i.e., unattended) parts of a briefly presented letter array are sometimes illusorily perceived as upright. Presumably, the expectation that letters are generally seen upright modulated a rotated le...
Abstract
Frontiers in cardiovascular medicine,
Volume 12, 17 3 2025, Pages 1708865
Exploring ethnic differences in the perioperative course of thoracic aortopathy.
Bacour N, Tirpan AU, Grewal S, Klautz RJM, Grewal N
Background: In patients with thoracic aortopathy post-operative recovery can be complicated by a lack of consistent, clear communication and guidance. Despite the growing recognition of these challenges, the specific needs of patients undergoing aortic surgery, especially across different ethnic groups, remain insufficiently explored. This study aims to examine the peri-operative course in thoracic aortopathy in order to identify the specific needs of the patients, particularly across ethnic gro...
Abstract
JACC. Clinical electrophysiology,
13 2 2025, Pages S2405-500X(25)00824-2
Characterizing Sustained Arrhythmias in Patients With Arrhythmic Mitral Valve Prolapse: Insights From the SAVE-MVP collaboration.
Sabbag A, Ajmone-Marsan N, Ezzeddine F, Ascione G, Guicciardi NA, Baudinaud P, Beinart R, Ben Kilani M, Bergonti M, Bhardwaj PK, Boveda S, Czimbalmos C, Cristin L, Conte G, Del Carpio F, Delling F, de Riva M, Deharo JC, Escande W, Font J, Foltran D, Guerra F, Guenancia C, Haugaa KH, Haddad C, Hermida A, Huttin O, Jacon P, Krebsová A, Laredo M, Lim HS, López-Santi P, Maury P, Mansourati J, Milman A, Mazor E, Nagy A, Przybylski A, Saba M, Sohns C, Sticherling C, Siontis KC, Ter Bekke RMA, Tixier R, Acha MR, Richard-Vitton R, Winkel BG, Ollitrault P, Aabel EW
Background: Arrhythmic mitral valve prolapse (AMVP) is a cause of sustained ventricular tachyarrhythmias (VAs) and sudden cardiac death (SCD), but the arrhythmias remain only partially understood. Objectives: In this worldwide collaboration, this study aimed to characterize the VAs occurring in AMVP patients, explore factors associated with various types of sustained VA, and describe common triggering mechanisms. Methods: In this multicenter retrospective cohort study, we collected patients with...
Abstract
Nederlands tijdschrift voor geneeskunde,
Volume 169, 13 2 2025, Pages D8782
[Cognitive bias in surgery: correctable failure or inevitably human?]
Hamming JF, Adriaanse MA
A review in the Annals of Surgery addressed the role of cognitive bias and heuristics in creating surgical complications and death. Bias and heuristics in decision making is not new, but the fact that surgeons and clinicians in general are influenced by them is apparently still noteworthy. The idea that clinicians act purely rational or should persists. But doctors are not computers. Nevertheless interventions aiming at improving behaviour of clinicians is based on the assumption that more knowl...
Abstract
International journal of cardiology,
Volume 444, 11 2 2025, Pages 134023
Sex differences in plaque burden and outcomes in symptomatic patients with suspected coronary artery disease.
Molnar D, Knuuti J, Bax JJ, Saraste A, Maaniitty T
Background: Sex-related differences in coronary artery disease (CAD) burden and outcomes are increasingly recognized but not fully understood, particularly when assessed using advanced imaging techniques. Objectives: To investigate sex differences in coronary plaque characteristics and their association with long-term cardiovascular outcomes in symptomatic patients undergoing coronary computed tomography angiography (CTA). Methods: A total of 2271 symptomatic patients without prior obstructive C...
Abstract
The Pediatric infectious disease journal,
11 2 2025
Pediatric Preseptal and Orbital Cellulitis: A Comparative Study of Clinical, Radiologic, and Laboratory Features.
Şahin A, Tanriverdi Kaymaz C, Kara Aksay A, Pekçevik Y, Ekemen Keleş Y, Üstündağ G, Elvan Tüz A, Tasar S, Arslan Maden A, Karadağ Öncel E, Yilmaz D
Background: This study aimed to evaluate and compare the clinical, laboratory and radiologic characteristics, as well as treatment approaches, in pediatric patients diagnosed with preseptal and orbital cellulitis. Methods: This descriptive, retrospective, cross-sectional study included pediatric patients treated at a tertiary care center between January 2019 and December 2023. Demographic, clinical, etiologic, laboratory and radiologic data were analyzed. Results: Among 244 patients, 233 (95.5%)...
Abstract
Frontiers in cardiovascular medicine,
Volume 12, 10 2 2025, Pages 1682714
Nordic consensus document on Evolut FX+ transcatheter aortic valve implantation: optimizing index implantation and longer-term outcomes.
Khokhar AA, Savontaus M, Al-Ani A, Terkselsen CJ, Bieliauskas G, van der Heijden A, Amin AAA, James S, Russell K, De Backer O
Transcatheter aortic valve replacement (TAVI) is an established treatment strategy for patients with severe symptomatic aortic stenosis (AS). Multiple landmark randomized controlled trials have consistently demonstrated the safety, efficacy, and longer-term durability of the CoreValve/Evolut (Medtronic, MN, USA) transcatheter aortic valve (TAV) platform in treating severe AS. These findings have supported the expansion of TAVI to younger patients with longer life expectancy, in whom an optimized...
Abstract
European heart journal. Case reports,
Volume 9, Issue 12, 10 2 2025, Pages ytaf561
Giant coronary artery aneurysms: a case series and management recommendations.
Vink AS, Grundeken MJD, Straver B, Robbers-Visser D, Bouma BJ, Koolbergen DR, De Winter RJ, Beijk MAM
Background: Coronary artery aneurysms (CAAs) are a rare clinical entity, and little is known about their natural history, prognosis, and management. Invasive management of patients with CAA is challenging not only because of this limited understanding but also due to the technical challenges associated with both percutaneous and surgical interventions. Case summary: We describe the management of seven cases with giant CAAs in an elective setting. Our first case demonstrates successful percutaneo...
Abstract
BJPsych open,
Volume 11, Issue 6, 10 2 2025, Pages e271
Reducing functional dysconnectivity in people with schizophrenia spectrum disorders.
Wunderlich S, Keeser D, Spaeth J, Yilmaz D, Maurus I, Alici C, Schmitt A, Falkai P, Stoecklein S, Roell L
Background: The dysconnection hypothesis of schizophrenia posits that widespread synaptic inefficiencies lead to altered macroscale brain connectivity, contributing to symptom severity and cognitive deficits in individuals with schizophrenia spectrum disorders (SSD). Emerging evidence suggests that physical exercise may help to ameliorate these connectivity abnormalities and associated clinical impairments. Aims: This study investigated whether reductions in functional dysconnectivity following...
Abstract
Cited 2 times since 2025 (12.1 per year)
source: EuropePMC
NEJM evidence,
Volume 5, Issue 1, 10 2 2025, Pages EVIDoa2500268
Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.
Van't Hof AWJ, Gibson CM, Rikken SAOF, Januzzi JL, Granger CB, van Beurden A, Rasoul S, Ruiters L, Vainer J, Verburg A, Arslan F, Jukema JW, Durieux M, Polad J, van Vliet R, van den Branden BJL, Magro M, Remkes W, Beelen J, Hermanides R, Tolsma R, Gosselink M, Vinereanu D, Chioncel V, van de Hoef TP, Boomars R, Arkenbout KE, van Houwelingen GK, Hengstman G, van de Wetering H, Pisters R, Kala P, Merkely B, Ecollan P, Lapostolle F, Giugliano RP, Welsh RC, Levy M, Arias-Mendoza A, Baron N, Cociorva D, Wittes J, Unger EF, Coller BS, Ten Berg JM, Montalescot G
Background: Zalunfiban is a glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor designed for subcutaneous administration on first medical contact with patients with suspected ST-segment elevation myocardial infarction (STEMI). Methods: An international, double-blind, placebo-controlled trial randomly assigned patients with STEMI in a 1:1:1 ratio to receive a single subcutaneous injection of zalunfiban (0.11 mg/kg or 0.13 mg/kg) or placebo. The primary efficacy end point was a hierarchical proporti...
Abstract
Thrombosis research,
Volume 256, 9 2 2025, Pages 109533
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score.
van der Horst SFB, Chu G, Seelig J, Trinks-Roerdink EM, Voorhout L, de Vries TAC, van Alem AP, Beukema RJ, Boersma LVA, Brouwer MA, Ten Cate H, Faber LM, de Groot JR, Gu YL, den Hartog FR, de Jong JSSG, de Jong Y, Kirchhof CJHJ, Kleijwegt FS, Klok FA, Kruip MJHA, Lenderink T, Luermans JG, Meeder JG, Otten AM, Pisters R, Pos L, Prins FJ, Römer TJ, Smeets F, Tahapary GJM, Theunissen LJHJ, Tieleman RG, Timmer SAJ, Tichelaar V, Trines SA, van der Voort P, Velthuis S, de Vrey EA, Walhout RJ, Hemels MEW, Rutten FH, Geersing GJ, Huisman MV
Background: Atrial fibrillation/flutter (AF/AFL) is associated with an increased stroke risk, for which oral anticoagulation (OAC) is often indicated. Bleeding risk assessment is crucial in these patients to mitigate bleeding complications, yet AF guidelines do not recommend the use of any bleeding risk score (e.g., HAS-BLED) due to concerns about predictive accuracy. The AF-adapted VTE-BLEED (AF-BLEED) score was developed to predict major bleeding (MB) post-OAC initiation. Aims: Evaluate the in...
Abstract
The Journal of invasive cardiology,
7 1 2025
Vascular access and mortality outcomes: insights from the Percutaneous Coronary Interventions registry from the Netherlands Heart Registration.
Karalis I, Timmermans MJ, Tuccillo A, Jukema JW, Derks L, Verbeek EC, Amoroso G, PCI Registration Committee of the Netherlands Heart Registration (NHR)
Objectives: While the transradial approach (TRA) is associated with fewer bleeding complications than the transfemoral approach (TFA), its effect on mortality outcomes in real-world clinical practice remains unclear. This study examines the relationship between vascular access site and mortality in patients undergoing percutaneous coronary intervention (PCI). Methods: This retrospective cohort study used prospectively collected data from the Netherlands Heart Registration, including 130,813 PCI...
Abstract
Multiple sclerosis (Houndmills, Basingstoke, England),
Volume 31, Issue 14, 6 1 2025, Pages 1641-1650
Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves JS
Background: Age is the strongest factor determining disease expression in multiple sclerosis (MS). We previously demonstrated biological age acceleration in pediatric-onset MS (POMS) compared to controls with both epigenetic clocks (DNAm) and telomere length (TL). It is unknown whether these markers report overlapping or distinct aging-related processes. Objectives: To determine the correlation between DNAm and TL aging markers. Methods: We conducted a cross-sectional case-control study within t...
Abstract
Journal of the American Heart Association,
Volume 14, Issue 22, 6 1 2025, Pages e040726
Prognostic Value of a Coronary Computed Tomography Angiography-Derived Ischemia Algorithm: Comparison Against Hybrid Coronary Computed Tomography Angiography/Positron Emission Tomography Imaging.
Maaniitty T, Bär S, Nabeta T, Bax JJ, Saraste A, Knuuti J
Background: Artificial intelligence-guided quantitative computed tomography ischemia (AI-QCTischemia) is a novel machine-learning method for predicting myocardial ischemia from coronary computed tomography angiography (CCTA). This observational cohort study aimed to compare the long-term prognostic value of AI-QCTischemia with hybrid CCTA/positron emission tomography (PET) myocardial perfusion imaging in suspected coronary artery disease (CAD). Methods: Symptomatic patients with suspected CAD un...
Abstract
American heart journal,
Volume 292, 3 1 2025, Pages 107295
Evolocumab before percutaneous coronary intervention for acute myocardial infarction: Design of the AMUNDSEN trial.
Montalescot G, Bolognese L, Bartus S, Cequier-Fillat A, Thiele H, Mach F, Jukema JW, Ferrari E, Souteyrand G, Bouleti C, Range G, Chioccioli M, Picchi A, Batias-Moreau L, Esposito G, Braik N, Redjimi N, Duband B, Guedeney P, Zeitouni M, Brochard K, Silvain J, Vicaut E, AMUNDSEN investigators of the ACTION Study Group
Rationale: PCSK9 inhibitors are currently recommended as third-line therapy for post-myocardial infarction (MI) patients, added to high-dose statin, ezetimibe, and potentially bempedoic acid when the LDL-C target of
Abstract
Cited 30 times since 2025 (157.6 per year)
source: EuropePMC
European heart journal,
Volume 46, Issue 44, 1 1 2025, Pages 4635-4736
2025 ESC/EACTS Guidelines for the management of valvular heart disease.
Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, Ajmone Marsan N, Barili F, Bonaros N, Cosyns B, De Paulis R, Gamra H, Jahangiri M, Jeppsson A, Klautz RJM, Mores B, Pérez-David E, Pöss J, Prendergast BD, Rocca B, Rossello X, Suzuki M, Thiele H, Tribouilloy CM, Wojakowski W, ESC/EACTS Scientific Document Group
Abstract
Expert opinion on biological therapy,
Volume 25, Issue 11, 1 1 2025, Pages 1171-1192
Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.
Boesjes CM, van der Gang LF, Achten RE, Bakker DS, van der Rijst LP, Dekkers CC, van Wijk F, Haeck IM, de Bruin-Weller MS, de Graaf M
Introduction: Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disorder and has a considerable impact on patients' quality of life. Dupilumab, the first biologic approved for moderate-to-severe AD, is a human monoclonal antibody targeting the interleukin (IL)-4 receptor α, thereby blocking both IL-4 and IL-13 signaling, key drivers of type 2 inflammation in AD. Its introduction has marked a paradigm shift in the management of AD and paved the way for future therapies. As real...
Abstract
Lancet (London, England),
Volume 406, Issue 10519, 1 1 2025, Pages 2577-2587
Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
van der Bijl P, Gulati M, Saraste A, Marwick T, Kwong R, Blankstein R, Nieman K, Sengupta PP, van Rosendael A, Knuuti J, Bangalore S, Bax JJ
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an acute coronary syndrome, it is often characterised by long periods of stability, known as chronic coronary artery disease. This Review presents a comprehensive overview of the diagnosis of the disease, with a focus on cardiac imaging. We discuss various cardiac imaging modalities, including CT coronary angiography, stress echocardiogram, stress single-photon emission CT, PET...
Abstract
